Weng et al15 found that ciRS‐7 was a promising prognostic biomarker in colorectal cancer patients and may be served as a therapeutic target for reducing EGFR‐RAF1 activity in colorectal cancer patients. The gene discussed is RAF1; the disease is colorectal cancer.